期刊文献+

黑龙江地区云南白药胶囊临床安全性集中监测统计与分析 预览

Statistical Analysis of Clinical Safety on Centralized Monitoring of Yunnan Baiyao Capsules in Heilongjiang Province
在线阅读 下载PDF
收藏 分享 导出
摘要 目的探讨云南白药胶囊不良反应发生的影响因素,促进临床合理用药。方法采用巢式病例对照研究法,以集中监测中出现严重不良反应的患者作为病例,以未发生不良反应的患者为对照,收集其临床资料及其他特征,进行对照研究。结果收集的906例服用云南白药胶囊的病例中,出现不良反应1例,发生率为0. 11%。结论云南白药胶囊在合并用药的情况下,临床大样本集中监测发现未知或罕见不良反应极少且临床症状轻微。 Objective To investigate the influencing factors of adverse drug reactions caused by Yunnan Baiyao Capsules and to promote rational drug use in clinic. Methods Nested case-control study was adopted to collect clinical data and other characteristics of patients for case-control study by taking the patients with severe adverse reactions during centralized monitoring as ″cases″ and the patients without adverse reactions during centralized monitoring as ″controls″. Results Among 906 patients treated with Yunnan Baiyao Capsules,1 case had adverse reactions,the incidence rate was 0. 11%. Conclusion In the cases of Yunnan Baiyao Capsules combined with the other drugs,the centralized monitoring of large clinical samples shows that unknown or rare adverse drug reactions were very few and the clinical symptoms were mild.
作者 肖莹 周继承 冯春 罗先国 白玉江 XIAO Ying;ZHOU Jicheng;FENG Chun;LUO Xianguo;BAI Yujiang(The 962th Hospital of Joint Logistic Support Force of PLA,Harbin,Heilongjiang,China 150001;People's Hospital of Daqing,Daqing,Heilongjiang,China 163000;The First Hospital of Qiqihar,Qiqihar,Heilongjiang,China 161000;The Third Hospital Affiliated to Qiqihar Medical College,Qiqihar,Heilongjiang,China 161000)
出处 《中国药业》 CAS 2019年第12期114-116,共3页 China Pharmaceuticals
关键词 云南白药胶囊 安全性再评价 药品不良反应 药品不良事件 巢式病例对照 合理用药 Yunnan Baiyao Capsules safety re-evaluation adverse drug reactions adverse drug events nested case-control rational drug use
作者简介 第一作者:肖莹,男,副主任医师,主要从事内科胃肠病的临床研究,(电话)0451-83852561,(电子信箱)13796828573@139.com。
  • 相关文献

参考文献14

二级参考文献200

共引文献347

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈